News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 253–288
- Matches
- 1581
- Sources here
- 14
- Companies here
- 18
Active search
1581 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
4,055 Shares in Chubb Limited $CB Bought by One Wealth Advisors LLC
One Wealth Advisors LLC recently acquired 4,055 shares of Chubb Limited, valued at approximately $1.38 million. This purchase is part of broader institutional investment in Chubb, with hedge funds and other institutional investors collectively owning 83.81% of the company's stock. Chubb reported strong quarterly …
ABBV Financials: Income Statement, Balance Sheet & Cash Flow
This article provides a detailed financial analysis of AbbVie Inc. (ABBV) for fiscal year 2025, covering its income statement, balance sheet, and cash flow. Key insights include a revenue increase to $61.2B but a slight net income decrease, strong cash flow despite deteriorating equity, …
(RBB) and the Role of Price-Sensitive Allocations
This article provides an AI-generated analysis of Rbb Bancorp (NYSE: RBB), indicating a strong near-term sentiment that may lead to a long-term positive bias. It highlights a mid-channel oscillation pattern and presents three institutional trading strategies: Position Trading, Momentum Breakout, and Risk Hedging, complete …
Bristol Myers Squibb Company $BMY Holdings Raised by Principal Financial Group Inc.
Principal Financial Group Inc. increased its holdings in Bristol Myers Squibb Company (BMY) by 9.8% in the second quarter, now owning 2.55 million shares valued at $146.9 million. This occurred as Bristol Myers Squibb reported strong quarterly earnings, beating estimates with $2.04 EPS and …
Synergy Asset Management LLC Grows Stock Position in AbbVie Inc. $ABBV
Synergy Asset Management LLC significantly increased its stake in AbbVie Inc. (NYSE:ABBV) by 703.9% in the second quarter, bringing its total holdings to 180,179 shares valued at $45.34 million. AbbVie now represents 4.3% of Synergy's portfolio, with other major institutional investors also adjusting their …
Southeast Asset Advisors, LLC's Hubbell Inc(HUBB) Holding History
This article details Southeast Asset Advisors, LLC's investment in Hubbell Inc (HUBB) as of June 30, 2026. The firm holds 5,711 shares valued at $2.99 million, representing 0.3% of its portfolio. With an average purchase price of $504.83 per share and a current price …
Royal Caribbean Officially Welcomes Legend of the Seas to the Revolutionary Icon Class, Built in Collaboration With Meyer Turku
Royal Caribbean officially welcomed the Legend of the Seas, the third Icon Class ship, built in collaboration with Meyer Turku. The ship, which is LNG-powered, will debut in Europe in July 2026 for Western Mediterranean cruises before heading to Fort Lauderdale in November for …
AbbVie Defends Its Turf, But Leaves One Big Question Open
AbbVie (ABBV) is performing strongly, with its stock up and sales growth beating expectations, though its EPS guidance was slightly trimmed due to an acquisition. While the company successfully defended its SKYRIZI sales against new competition, analysts are still concerned about its future pipeline …
Sharemaestro market context Trend signal active 52 weeks +40.4% · Next-week setup negative 42.8%What Does Bristol Myers Squibb (BMY) Risk From The Revived $6.7 Billion Lawsuit?
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Bristol Myers Squibb (NYSE:BMY) is facing a revived US$6.7b lawsuit after a federal appeals court reinstated claims tied to its Celgene acquisition. Plaintiffs allege the …
Sharemaestro market context Trend signal active 52 weeks +58.2% · Next-week setup positive 55.1%AbbVie (ABBV) Stock May Trade At A Premium Despite Cash Flow Upside
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. AbbVie stock has delivered a strong 152.2% return over the past 5 years, yet the valuation signals are split, with a Discounted Cash Flow (DCF) intrinsic value …
Sharemaestro market context Trend signal active 52 weeks +40.4% · Next-week setup negative 42.8%45,829 Shares in RBB Bancorp $RBB Bought by Walleye Capital LLC
Walleye Capital LLC recently acquired 45,829 shares of RBB Bancorp (NASDAQ:RBB) for approximately $1.26 million, marking a new position for the firm. This acquisition is part of broader institutional investment, with hedge funds and other investors owning over 40% of the company. RBB Bancorp …
Oppenheimer Asset Management Inc. Buys New Shares in Chubb Limited $CB
Oppenheimer Asset Management Inc. acquired 118,585 shares of Chubb Limited, valued at approximately $40.4 million, during the second quarter. Institutional investors hold 83.81% of Chubb's stock, while corporate insiders own 0.37%. The company recently exceeded earnings expectations, reporting $7.26 EPS against a $6.77 estimate, …
Mill Capital Management LLC Makes New Investment in Chubb Limited $CB
Mill Capital Management LLC recently invested in Chubb Limited (NYSE:CB), purchasing 3,210 shares valued at $1.09 million in Q2. Institutional investors and hedge funds now own 83.81% of the company. Despite recent insider share sales, Chubb reported strong quarterly earnings, beating consensus estimates, and …
Northstar Group Inc. Takes $1.72 Million Position in Chubb Limited $CB
Northstar Group Inc. has acquired a new position in Chubb Limited (NYSE:CB), purchasing 5,032 shares valued at approximately $1.72 million during the second quarter. Chubb recently reported strong quarterly earnings of $7.26 per share, exceeding analyst estimates, and declared a quarterly dividend of $1.02 …
Park National Corp OH Lowers Stake in Abbott Laboratories $ABT
Park National Corp OH reduced its stake in Abbott Laboratories by 10.2% in the second quarter, selling 17,000 shares but still retaining 150,182 shares valued at approximately $13.6 million. Despite this reduction and some analysts lowering price targets, the consensus rating for Abbott remains …
QRG Capital Management Inc. Lowers Holdings in Abbott Laboratories $ABT
QRG Capital Management Inc. reduced its stake in Abbott Laboratories (NYSE:ABT) by 28.7% in the second quarter, selling 83,416 shares and retaining 207,173 shares worth approximately $18.8 million. Despite this reduction, institutional investors collectively own 75.18% of ABT. Abbott Laboratories recently reported stronger-than-expected quarterly …
Abbott Laboratories Revenue Breakdown – AQUISUK:ABLD
This article provides a revenue breakdown for Abbott Laboratories (ABLD) on the Aquis Stock Exchange. It highlights that in the last year, the company generated 37.74 billion EUR, with Medical Devices being the top-performing segment at 18.21 billion EUR. The United States was the …
Bristol Myers Squibb (BMY) Stock May Be 46% Undervalued As FDA Approval Lands
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Bristol-Myers Squibb stock has delivered a 38.1% gain over the past year, while valuation …
Sharemaestro market context Trend signal active 52 weeks +58.2% · Next-week setup positive 55.1%Ribbon Attends Two Investor Conferences in August
Ribbon Communications Inc. (Nasdaq: RBBN) announced its attendance at two investor conferences in August 2026. The company will participate in the Rosenblatt 6th Annual Tech Summit on August 17-18 and the Jefferies Semiconductor, IT Hardware & Communications Technology Conference on August 25. Ribbon is …